Abdulaziz Alamri

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Minimally Invasive

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia Papadakos, Hawraa Issa, Abdulaziz Alamri, Abdullah M Alamri, Abdelhabib Semlali
Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Sofia Papadakos, Hawraa Issa, Abdulaziz Alamri, Abdullah M Alamri, Abdelhabib Semlali
Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Sofia Papadakos, Hawraa Issa, Abdulaziz Alamri, Abdullah M Alamri, Abdelhabib Semlali
Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)